Patents by Inventor Fred L. Heffron

Fred L. Heffron has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 7972607
    Abstract: Francisella tularensis is the bacterial pathogen that causes tularemia in humans and a number of animals. To date, no approved vaccine exists for this widespread and life-threatening disease. The present disclosure provides attenuated Francisella mutants that include functional deletions in one or more of the dsbB, FTT0742, pdpB, fumA, and carB genes. Also provided are immunogenic compositions that include the attenuated bacteria. Methods are provided for treatment using the attenuated Francisella mutants.
    Type: Grant
    Filed: November 3, 2006
    Date of Patent: July 5, 2011
    Assignee: Oregon Health & Science University
    Inventors: Rebecca Tempel, Xin-He Lai, Fred L. Heffron
  • Publication number: 20100233211
    Abstract: Francisella tularensis is the bacterial pathogen that causes tularemia in humans and a number of animals. To date, no approved vaccine exists for this widespread and life-threatening disease. The present disclosure provides attenuated Francisella mutants that include functional deletions in one or more of the dsbB, FTT0742, pdpB, fumA, and carB genes. Also provided are immunogenic compositions that include the attenuated bacteria. Methods are provided for treatment using the attenuated Francisella mutants.
    Type: Application
    Filed: November 3, 2006
    Publication date: September 16, 2010
    Applicant: OREGON HEALTH & SCIENCE UNIVERSITY
    Inventors: Rebecca Tempel, Xin-He Lai, Fred L. Heffron
  • Patent number: 6846622
    Abstract: A transposable element is provided that as a 3? and a 5? end. The transposable element includes a 5? recombining site 5? of a nucleic acid sequence encoding a selectable marker, a 3? recombining site 3? of the nucleic acid sequence encoding a selectable marker, a nucleic acid sequence encoding and MHC epitope 5? to the 5? recombining site or 3? to the 3? recombining site, and an insertion end comprising an inverted repeat sequence sufficient for integration of the transposable element at the 5? and the 3? end of the transposable element. In one embodiment, a transposable element is provided that has a 5? and a 3? end. The transposable element includes a 5? loxP sequence 5? of a nucleic acid encoding a selectable marker, a 3? loxP sequences 3? of a nucleic acid encoding the selectable marker, an MHC epitope 5? to the 5? loxP sequences or 3? of the 3? loxP sequence, an insertion end at the 5? end of the transposable element, and an insertion end at the 3? of the transposable element.
    Type: Grant
    Filed: May 26, 2000
    Date of Patent: January 25, 2005
    Assignee: Oregon Health & Science University
    Inventors: Fred L. Heffron, David C. Parker, Dolph D. Ellefson